MedTrace Logo

Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta

NCT00819897 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2016-05-12

No results posted yet for this study

Summary

The aim of this study is to evaluate the role of cognitive disorders and quality of life in patients with CIS, considered as high risk to develop an MS, treated with interferon Beta. This prospective observational study will include 120 patients, all treated and evaluated annually with neurological extensive examination, ophthalmologic screening (OCT, OF, VEP, VF), auto questionnaire about fatigue (musicol, ELIF), quality of life (SEP-59), and conventional MRI.

Conditions

  • Clinically Isolated Syndrome

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Principal Investigators

  • Christine LEBRUN-FRENAY, MDPH · University hospital of Nice

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00819897 on ClinicalTrials.gov